Updates to GenomOncology’s Platform Expand Company’s Footprint in Clinical NGS Market

In the two years since it launched proprietary software solutions for next-generation sequence data analysis, GenomOncology has expanded its platform to include a number of additional applications that cater to a much broader range of analysis and interpretation needs. (read more)